The latest medical news, expert views on key health issues, as well as advice on disease prevention and management.
Articles on endocrinology
Tirzepatide (branded Munjaro) improves blood sugar metabolism in patients with obesity and type 2 diabetes. It is able to reduce body weight by up to 26.6% on average. This was evidenced by the results of SURMOUNT-3 and SURMOUNT- 4, two Phase 3 drug trials. Until now, the its effect on metabolism was not fully understood. Recently scientists have managed to uncover this mechanism.
New generation antidiabetic drugs, which appeared on the market relatively recently, are rightfully considered a breakthrough in the treatment of this widespread and dangerous disease. At the same time, they are not only able to regulate blood sugar levels, but also to fight the frequent "companion" of diabetes - obesity.
Diabetes mellitus is one of the most common conditions. There are several forms of the disease, differing in cause and course, although in the background is always a disorder of glucose metabolism in the body. Correct and timely diagnosis plays a crucial role in finding the right treatment and monitoring scheme. This means that it is possible to maintain the quality of life for as long as possible, avoiding or minimizing complications. However, it is at the time of diagnosis that mistakes occur quite often.